glp 1 compound fda issued 25 warning letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of GLP-1 compounding is still in

We expense all research and development costs in the periods in which they are incurred

In our clinical experience, most patients notice meaningful improvement in digestive symptoms and brain fog within the first four to six weeks of a structured elimination diet combined with antifungal herbal therapy

Understanding the Mental Tug-of-War in Binge Eating Before we talk about the medication, we have to talk about the food noise first

Not peptides, but commonly offered alongside them Under FDA review BPC-157, TB-500, KPV, MOTS-C on the July 2026 agenda DSIP, Semax, Epitalon on the July 2026 agenda GHK-Cu second review by Feb 2027 CJC-1295 and Ipamorelin were declined in 2024 and remain restricted, not coming back via this process